Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis.
Okada
T
T
Nakao
T
T
Matsumoto
H
H
Nagaoka
Y
Y
Iwasawa
H
H
Nanri
K
K
Yamazaki
T
T
D000212:Acyclovir / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D000077483:Valacyclovir; D014633:Valine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*
D000998:Antiviral Agents; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir